Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision linezolid dosing model in ICU patients with renal insufficiency
ChiCTR2100048473Phase 4Not yet recruiting
- Sponsor
- Affiliated Suzhou Hospital of Nanjing Medical University
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of linezolid in bacterial disease and Renal Insufficiency (RI), sponsored by Affiliated Suzhou Hospital of Nanjing Medical University. Primary endpoint: Thrombocytopenia. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
linezolid
03
Conditions
bacterial diseaseRenal Insufficiency (RI)
Beyond the preview
Go deeper on ChiCTR2100048473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048473.